Lexicon Pharmaceuticals, Inc./De - Current report filing (8-K)
May 06 2008 - 4:25PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
__________________
FORM
8-K
__________________
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): April 30, 2008
Lexicon
Pharmaceuticals, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
|
000-30111
|
76-0474169
|
(State
or other jurisdiction of
incorporation
or organization)
|
(Commission
File Number)
|
(I.R.S.
Employer
Identification
Number)
|
8800
Technology Forest Place
The
Woodlands, Texas 77381
(Address
of principal executive
offices
and Zip Code)
(281)
863-3000
(Registrant’s
telephone number,
including
area code)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligations of the registrant under any of the following
provisions:
|
□
|
Written
communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
|
|
□
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
□
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
|
|
□
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))
|
Item
1.01
|
Entry
into a Material Definitive
Agreement
|
On
April 30, 2008, we entered into an amendment to our Economic Development
Agreement (the “Agreement”) dated as of July 15, 2005 with the State of Texas
and the Texas A&M University System, pursuant to which the timeline relating
to our jobs creation obligations was modified without changing the aggregate
number of jobs we are responsible for creating under the Agreement.
Item
9.01
|
Financial
Statements and Exhibits
|
(d) Exhibits
Exhibit
No.
|
|
Description
|
10.1
|
—
|
Amendment,
dated April 30, 2008, to Economic Development Agreement, dated July 15,
2005, with the State of Texas and the Texas A&M University
System
|
Signatures
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
Lexicon
Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
|
Date: May
6, 2008
|
By:
|
/s/
Jeffrey L. Wade
|
|
|
Jeffrey
L. Wade
|
|
|
Executive Vice
President
and
|
|
|
General
Counsel
|
Index
to Exhibits
Exhibit
No.
|
|
Description
|
10.1
|
—
|
Amendment,
dated April 30, 2008, to Economic Development Agreement, dated July 15,
2005, with the State of Texas and the Texas A&M University
System
|
Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jul 2023 to Jul 2024